Investor Presentation • Aug 7, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
AUGUST 7TH, 2025



| emarket sdir storage |
|---|
| CERTIFIED |






EBITDA ex NRIs €99m
New Business 1 €11bn
Note: (1) Including committed mandates and excluding secondary deals on existing portfolios; (2) On a pro forma basis
Financial Leverage 2.3x

BB stable outlook
Non-NPL revenue 37%

Continued commercial momentum: €800 million new mandates since May, largely driven by new mandates won in Spain from a leading banking institution and by new UTP mandates in Italy
Strong progress from Forward Flows which stood at €2.1 billion well over our initial annual target of €2.0 billion. This performance was mainly driven by solid flows from Santander in Spain (+42% YoY), and of the significant contribution of BPER and Banco BPM

Maintained servicing on €1.1 billion portfolios following secondary sales in Greece, evidence of the high quality of doValue's servicing
1.1
New business from locked-in contracts replenished ~85% of collections in H1 2025, contributing to GBV stabilization





| emarket sdir storage |
|---|
| CERTIFIED |
New New initiatives related to 24-26 Business Plan



OUR NEXT GROWTH HORIZON: The 2026-2028 industrial plan will define our new ambitions and opportunities for the future
Mid 2026



Gross Revenue




| ∆% YoY |
|
|---|---|
| • Continued double-digit growth in gross revenue vs. prior year • Non-NPL revenue drove more growth than NPL in H1 25 • Continued strong momentum in VAS, with revenue increased double digit |
|
| • Higher net revenue driven by a contained impact of consolidation on outsourcing costs which decreased as % of gross revenue YoY |
|
| • Double-digit growth in EBITDA continued in 2Q • Growth supported by cost savings in Iberia and the successful release of synergies in Italy |
|
| • Strong improvement in EBITDA margin YoY in 2Q, thanks to continued cost discipline alongside the expansion of higher margin business |
|
| • Strong double-digit growth in Net Income ex NRIs (+80%) thanks to the positive trend in EBITDA ex NRIs and despite higher financial interest and minorities |

Note: in H1 2024 figures Portugal is included in non recurring items due to its sale in July 2024
• Revenue flat YoY as strong dynamics in VAS and REOs offset the lower disposals impacting NPL revenue in 2Q
• Overall revenue up +86% YoY, driven by Gardant contribution and very positive trends in recurring VAS
• Revenue only slightly down by €(1.8) million YoY due to lower REOs mitigated by continued improvement in all other categories

Note: in H1 2024 figures Portugal is included in non recurring items due to its sale in July 2024

• Operating costs increased only by €3.9 million YoY thanks to efficiencies in Iberia and Greece, as well as initial synergies that were able to successfully mitigate the effect of Gardant's consolidation
Notes:
In H1 2024 figures Portugal is included in non recurring items due to its sale in July 2024. Group costs fully allocated to Italy

| emarket sdir storage |
|---|
| CERTIFIED |

Notes:
In H1 2024 figures Portugal is included in non recurring items due to its sale in July 2024. Group costs fully allocated to Italy

| emarket sdir scorage |
|---|
| CERTIFIED |
| €m | H1 2025 |
H1 2024 |
Delta | COMMENTS |
|---|---|---|---|---|
| EBITDA ex NRIs | 99.1 | 67.4 | 31.8 | • Higher EBITDA ex NRIs driven by positive momentum across products and markets |
| Non-Recurring Items | (2.6) | (2.3) | (0.3) | • Write-downs on PP&E, intangibles, loans and equity investments in line with collection curves, includes also Gardant's portfolios • Higher financial interest and commission driven by the impact of the new bond (€8.4 million interest and amortized costs), the new term loan (€14.8 million interest and amortized costs) and the €7.3 million one-off costs related to the refinancing of the old 2026 bond |
| EBITDA | 96.5 | 65.0 | 31.4 | |
| Net write-down of PP&E, intangibles, loans and equity investments |
(46.3) | (42.1) | (4.2) | |
| EBIT | 50.2 | 23.0 | 27.3 | |
| Net financial interest and commission | (33.6) | (11.8) | (21.8) | • Income tax for the period increased on the back of a higher EBITDA as well as the consolidation of Gardant's. In 2024 the line was positively impacted by the tax claim gain in Spain |
| Net result of financial assets at fair value | 1.1 | (0.3) | 1.4 | |
| EBT | 17.6 | 10.9 | 6.8 | • Minorities increased due to Gardant's partnerships with Banco |
| Income tax | (13.2) | 8.7 | (21.8) | BPM and BPER |
| Minorities | (8.5) | (4.0) | (4.5) | • Non recurring items included €7.3 million costs related to the refinancing of the new bond as well as €7.3 million redundancy costs, largely in Italy to unlock synergies from Gardant |
| Group Net Income reported | (4.1) | 15.5 | (19.5) | |
| Non Recurring Items |
(16.0) | 8.6 | (24.6) | • Net income ex NRI up >70% vs prior year despite the c. €22 million increase in financial interest linked to the recent refinancing activities |
| Group Net Income ex NRIs | 11.9 | 6.9 | 5.0 | • Net income reported slightly improved YoY despite the higher NRIs, once excluded the effect of the €20m tax claim in 1H24 |
Note: in H1 2024 figures Portugal is included in non recurring items due to its sale in July 2024
| ohibited | emarke sdir scorage |
|---|---|
| CERTIFIED |
| €m | H1 2025 | H1 2024 | Delta (€m) |
|---|---|---|---|
| EBITDA | 96.5 | 65.0 | 31.4 |
| Capex | (8.0) | (6.6) | (1.3) |
| Change in NWC and accruals on share based payments |
22.5 | (10.7) | 33.2 |
| IFRS 16 | (10.1) | (6.9) | (3.2) |
| Redundancies | (5.7) | (4.2) | (1.5) |
| Other changes in other assets & liabilities |
(14.6) | (16.9) | 2.3 |
| Cash Flow from Operations | 80.6 | 19.6 | 61.0 |
| Taxes | (7.0) | (9.1) | 2.1 |
| Financial charges | (23.1) | (12.3) | (10.8) |
| Free Cash Flow | 50.5 | (1.8) | 52.3 |
| Minorities | (7.7) | 0.0 | (7.7) |
| Investments in equity & financial assets | (12.4) | (1.9) | (10.5) |
| Cash flow before dividend & financial debt |
30.4 | (3.7) | 34.1 |
| COMMENTS |
|---|
| • Cash flow from operations, equal to €80.6m, in 2024, +€61.0 million higher than LY (€19.6m) with a much higher cash conversion reaching 84% from 30% in H1 2024 |
| • Moderate decrease in Capex (€(1.3)m YoY), mainly driven by Gardant • Continues the remarkable reduction in NWC (+€33.2m YoY) thanks to improving control of invoicing cycle with SPVs in Greece • Lease payments up €3.2 million YoY due to Gardant's perimeter • Redundancies at €5.7 million in H1 2025, slightly up YoY • Other changes in other assets & liabilities stable YoY, with increase vs |
| Q1 25 mainly linked to the 2024 MBO with no effects in H2 |
| • Free cash flow of €50.5 million, up by a remarkable €52.3 million YoY driven by the higher cash flow from operations which more than offset the increase in financial charges related to the refinancing of the 2026 senior |
| secured bond and interest on the new term loan |
| • Minorities of €7.7 million related to the partnerships with BPER and Banco BPM. No further significant payments expected in 2025. |
| • Equity & financial assets investments equal to €(12.4)m mainly related to |
| the payment of the earnout for doValue Greece |
Net Debt (€m)
| COMMENTS | |
|---|---|
| (2) • Net leverage at 2.3x , continuing its deleverage path towards FY guidance (2.0x) even including the extraordinary cash out of €11 million earn-out related to doValue Greece paid in Q1, and the €8 million minorities paid in Q2 |
|
| Other liabilities TL (2) Maturity 10/2029 |
• Solid liquidity buffer of €262m, including €130m undrawn RCF lines (o/w €80m 3-year facilities), despite the payment of the first tranche of term loan amortization in June, decreasing gross debt by €26.3m • Stable corporate rating (BB/Stable Outlook), confirmed in July in the context of the announcement of the binding agreement signed for the acquisition of coeo |
| €300m SSN Maturity 02/2030 7.000% coupon (2) |
• Our bond trades at one of the lowest yields in the sector, with a YTM ~5%, mirroring lower perceived credit risk and investor confidence and unaffected by acquisition announcement |
| Cash on BS | • Average cost of debt at 6.21% |

Notes: (1) Pro forma including Gardant (2) Including accrued interests and fin. Assets measured at amortized cost (3) Pro forma including the collection by doValue Spain of an Earn Out of €22.7 million occurred in April 2024, as illustrated in Q1 2024 results release

| emarket sdir scorage |
|---|
| CERTIFIED |
Note: (1) Free cash flow after interest, to serve dividend and principal repayment (2) Leverage target before dividend payment


• Targets do not currently include any potential synergies, on which more details will be given at the next Capital Markets Day around mid 2026
• Upside offered by the conservative stance of the Business Plan targets including coeo, currently based on low-end doValue target and coeo buyer case
• doValue will reach its standalone leverage target of 2.0x in 2025, in 2026 leverage is expected to rise only moderately to 2.2x with fast deleveraging to 1.7x in 2027
• Portfolio key features:
• Very limited increase in net debt post acquisition, with leverage expected at 2.2x at the end of 2026.



Titolo breaker slide coeo Daniele della Seta Head of IR and M&A



| emarket sdir scorage |
|---|
| CERTIFIED |






• Commercial pipeline includes 30 potential clients in payments, telecom, insurance and other sectors in 2025-2026

• Smooth earnings accretion – no seasonality (maximum monthly deviation from average of +/-7%(2)) and no link to credit cycle

• coeo's management will own c.3% of the new entity – minority interest will have a minimal impact on doValue's financials


• Business model based on number of files processed not on collection rate




Note: EBITDA ex NRI for Italy excluding Group costs worth €7.0m
| Hellenic Region |
Italy | Spain | |
|---|---|---|---|
| €141bn | €44bn | €86bn | €11bn |
| €2.6bn | €0.9bn | €1.3bn | €0.3bn |
| 4.4% | 5.6% | 3.4% | 8.2% |
| €281m | €109m | €149m | €24m |
| €99m | €50m | €63m | €0.4m |
| 35.2% | 45.6% | 42.5% | 1.6% |

| emarket sdir storage |
|---|
| CERTIFIED |
GBV remains stable at highest level since 2022as natural GBV reduction is fully offset by strong inflows from existing clients and new business
Inflows from new clients: intakes by region worth €1.9bn from Italy, €6.1bn from the Hellenic Region, mainly NPLs, and €0.9bn from Spain


| emarket sdir scorage |
|---|
| CERTIFIED |
| Reclassified Income Statement | st Half 1 |
st Half 1 |
||
|---|---|---|---|---|
| (€/000) | 2025 | 2024 | Change € | Change % |
| NPL Servicing revenue | 175,880 | 143,552 | 32,328 | 22.5% |
| Non -NPL Servicing revenue |
50,620 | 40,776 | 9,844 | 24.1% |
| Value added services | 54,740 | 32,223 | 22,517 | 69.9% |
| Gross revenue | 281,240 | 216,551 | 64,689 | 29.9% |
| NPE Outsourcing fees | (10,130) | (5,781) | (4,349) | 75.2% |
| REO Outsourcing fees | (3,938) | (4,944) | 1,006 | (20.3)% |
| Value added services Outsourcing fees | (12,579) | (11,858) | (721) | 6.1% |
| Net revenue | 254,593 | 193,968 | 60,625 | 31.3% |
| Staff expenses | (119,478) | (94,380) | (25,098) | 26.6% |
| Administrative expenses | (38,627) | (34,545) | (4,082) | 11.8% |
| o.w. IT | (16,031) | (13,347) | (2,684) | 20.1% |
| o.w. Real Estate | (3,197) | (2,293) | (904) | 39.4% |
| o.w. SG&A | (19,399) | (18,905) | (494) | 2.6% |
| Operating expenses | (158,105) | (128,925) | (29,180) | 22.6% |
| EBITDA | 96,488 | 65,043 | 31,445 | 48.3% |
| EBITDA margin | 34.3% | 30.0% | 4.3% | 14.2% |
| Non -recurring items included in EBITDA |
(2,644) | (2,317) | (327) | 14.1% |
| EBITDA excluding non -recurring items |
99,132 | 67,360 | 31,772 | 47.2% |
| EBITDA margin excluding non -recurring items |
35.3% | 31.5% | 3.8% | 11.9% |
| Net write -downs on property, plant, equipment and intangibles |
(38,410) | (29,835) | (8,575) | 28.7% |
| Net provisions for risks and charges | (7,775) | (12,267) | 4,492 | (36.6)% |
| Net write -downs of loans |
(88) | 17 | (105) | n.s. |
| EBIT | 50,215 | 22,958 | 27,257 | 118.7% |
| Net income (loss) on financial assets and liabilities measured at fair value | 1,057 | (296) | 1,353 | n.s. |
| Net financial interest and commissions | (33,622) | (11,806) | (21,816) | n.s. |
| EBT | 17,650 | 10,856 | 6,794 | 62.6% |
| Non -recurring items included in EBT |
(17,253) | (11,639) | (5,614) | 48.2% |
| EBT excluding non -recurring items |
34,903 | 22,495 | 12,408 | 55.2% |
| Income tax | (13,190) | 8,649 | (21,839) | n.s. |
| Profit (Loss) for the period | 4,460 | 19,505 | (15,045) | (77.1)% |
| Profit (loss) for the period attributable to Non -controlling interests |
(8,513) | (4,011) | (4,502) | 112.2% |
| Profit (Loss) for the period attributable to the Shareholders of the Parent Company | (4,053) | 15,494 | (19,547) | (126.2)% |
| Non -recurring items included in Profit (loss) for the period |
(16,024) | 8,480 | (24,504) | n.s. |
| O.w. Non -recurring items included in Profit (loss) for the period attributable to Non -controlling interest |
(21) | (82) | 61 | (74.4)% |
| Profit (loss) for the period attributable to the Shareholders of the Parent Company excluding non -recurring items |
11,950 | 6,932 | 5,018 | 72.4% |
| Profit (loss) for the period attributable to Non -controlling interests excluding non -recurring items |
8,534 | 4,093 | 4,441 | 108.5% |
| Earnings per share (in Euro) | (0.021) | 1.001 | (1.023) | (102.1)% |
| Earnings per share excluding non -recurring items (Euro) |
0.063 | 0.448 | (0.385) | (85.9)% |




| Reclassified Statement of Financial Position | 6/30/2025 | 12/31/2024 | Change € | Change % |
|---|---|---|---|---|
| (€/000) | ||||
| Cash and liquid securities | 131,685 | 232,169 | (100,484) | (43.3)% |
| Financial assets | 48,807 | 49,293 | (486) | (1.0)% |
| Equity investments | 12 | 12 | - | n.s. |
| Property, plant and equipment | 56,890 | 52,305 | 4,585 | 8.8% |
| Intangible assets | 667,843 | 682,684 | (14,841) | (2.2)% |
| Tax assets | 92,521 | 105,200 | (12,679) | (12.1)% |
| Trade receivables | 214,942 | 263,961 | (49,019) | (18.6)% |
| Assets held for sale | 10 | 10 | - | n.s. |
| Other assets | 81,415 | 64,231 | 17,184 | 26.8% |
| Total Assets | 1,294,125 | 1,449,865 | (155,740) | (10.7)% |
| Financial liabilities: due to banks/bondholders | 614,920 | 733,419 | (118,499) | (16.2)% |
| Other financial liabilities | 74,900 | 76,675 | (1,775) | (2.3)% |
| Trade payables | 92,416 | 110,738 | (18,322) | (16.5)% |
| Tax liabilities | 108,002 | 108,989 | (987) | (0.9)% |
| Employee termination benefits | 11,458 | 11,913 | (455) | (3.8)% |
| Provisions for risks and charges | 21,235 | 23,034 | (1,799) | (7.8)% |
| Other liabilities | 63,062 | 73,046 | (9,984) | (13.7)% |
| Total Liabilities | 985,993 | 1,137,814 | (151,821) | (13.3)% |
| Share capital | 68,614 | 68,614 | - | n.s. |
| Share premium | 58,633 | 128,800 | (70,167) | (54.5)% |
| Reserves | 82,820 | 12,493 | 70,327 | n.s. |
| Treasury shares | (8,216) | (9,348) | 1,132 | (12.1)% |
| Profit (loss) for the period attributable to the Shareholders of the Parent Company | (4,053) | 1,900 | (5,953) | n.s. |
| Net Equity attributable to the Shareholders of the Parent Company | 197,798 | 202,459 | (4,661) | (2.3)% |
| Total Liabilities and Net Equity attributable to the Shareholders of the Parent Company | 1,183,791 | 1,340,273 | (156,482) | (11.7)% |
| Net Equity attributable to Non-Controlling Interests | 110,334 | 109,592 | 742 | 0.7% |
| Total Liabilities and Net Equity | 1,294,125 | 1,449,865 | (155,740) | (10.7)% |
| emarket sdir scorage |
|---|
| CERTIFIED |
| EBITDA Capex EBITDA-Capex as % of EBITDA Changes in Net Working Capital (NWC) |
96,488 (7,983) |
65,043 | |
|---|---|---|---|
| 154,045 | |||
| (6,647) | (23,769) | ||
| 88,505 | 58,396 | 130,276 | |
| 92% | 90% | 85% | |
| 22,512 | (10,730) | (4,719) | |
| Changes in other assets/liabilities | (30,404) | (28,038) | (41,885) |
| Operating Cash Flow | 80,613 | 19,628 | 83,672 |
| Corporate Income Tax paid | (6,993) | (9,060) | (25,656) |
| Financial charges | (23,144) | (12,350) | (29,777) |
| Free Cash Flow | 50,476 | (1,782) | 28,239 |
| (Investments)/divestments in financial assets | 1,018 | 1,445 | 2,848 |
| Equity and IFRS 15 contracts (investments)/divestments | (2,637) | (373) | (196,800) |
| Earn -out and Tax claim payment |
(10,800) | 400 | 400 |
| Treasury shares buy -back |
- | (3,421) | (3,421) |
| Transaction costs | - | - | (13,114) |
| Right Issue | - | - | 143,138 |
| Dividends paid to minority shareholders | (7,696) | - | - |
| Net Cash Flow of the period | 30,361 | (3,731) | (38,710) |
| Net financial Position - Beginning of period |
(514,364) | (475,654) | (475,654) |
| Net financial Position - End of period |
(484,003) | (479,385) | (514,364) |
| Change in Net Financial Position | 30,361 | (3,731) | (38,710) |

| emarket sdir storage |
|---|
| CERTIFIED |
Agreement with commercial bank related to the management of all future NPL generation by the bank for number of years, customary feature of credit servicing platforms spun off by
Full Time Equivalent, i.e. a unit that indicates the workload of an employed person in a way that makes workloads comparable across various contexts
Garanzia Cartolarizzazione Sofferenze, i.e. the State Guarantee scheme put together by the Italian Government in 2016 which favoured the creation of a more liquid NPL market in Italy
Gross Book Value, i.e. nominal value of assets under management by doValue, represents the maximum / nominal claim by banks / investors to borrowers on their portfolios
| Early Arrears | Loans that are up to 90 days past due |
|---|---|
| Forward Flows | commercial banks |
| FTE | Full Time Equivalent, i.e. a unit that indicates the workload of an employed person in a way that makes workloads comparable across various contexts |
| GACS | and allowed banks to more easily deconsolidate NPL portfolios through securitisations |
| GBV | |
| NPE | Non-Performing Exposure, i.e. the aggregate od NPL, UTP and Early Arrears |
| NPL | Non-Performing Loan, i.e. loans which are more than 180 days past due and have been denounced |
| NRI | Non-Recurring Items, i.e. costs or revenue which are non-recurring by nature (typically encountered in M&A or refinancing transactions) |
| Performing Loans | Loans which do not present problematic features in terms of principal / interest repayment by borrowers |
| REO | Real Estate Owned, i.e. real estate assets owned by a bank / investor as part of a repossession act |
| Stage 2 Loans | Subperforming loans – albeit not NP - that have seen a significant increase in credit risk, resulting in "investment grade" credit quality |
| UTP | Unlikely to Pay, i.e. loans that are between 90-180 days past due and denounced or more than 180 past due and not denounced |

| ctly prohibited | |
|---|---|
| emarket sdir storage |
|---|
| CERTIFIED |
This presentation is not a prospectus and not an offer of securities for sale to U.S. persons or in any jurisdiction, including in or into the United States, Canada, Japan or Australia.
This disclaimer applies to all documents and information provided herein and to any verbal or written comments of person presenting them by doValue S.pA. and its affiliates ("doValue"). or any person on behalf of doValue, and any question and answer session that follows the oral presentation (collectively, the "Information"). in accessing the Information, you agree to be bound by the following terms and conditions. The Information may not be reproduces redistributed, published or passed on to any other person, directly or indirectly, in whole or In part, for any purpose.
This presentation and any materials distributed in connection herewith, taken together with any such verbal or written comments, including the contents thereof and the Information (together, the "Presentation") is not intended for potential investors and do not constitute or form a part of, and should not be construed as, an offer for sale or subscription of or solicitation of any offer to purchase or subscribe any securities, and neither this Presentation nor anything contained herein shall form the basis of, or be relied upon in connection with, or act as an inducement to enter into, any contract or commitment whatsoever. Any such offer would only be made by means of formal offering documents, the terms of which shall govern in all respects.
You are cautioned against using this information as the basis for making a decision to purchase any security or to otherwise engage in an investment advisory relationship with doValue S.p.A. and its affiliates. The distribution of this Presentation in other jurisdictions may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restriction. Any failure to comply with these restrictions may constitute a violation of the laws of any such other jurisdiction.
This Presentation has been prepared based on the information currently available to us and is based on certain key underlying assumptions. The information contained in this Presentation has not been independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness, reasonableness or correctness of the information or opinions contained herein. None of doValue its subsidiaries or any of their respective employees, advisers, representatives or affiliates shall have any liability whatsoever (in negligence or otherwise) for any loss however arising from any use of this document or its contents or otherwise arising in connection with this Presentation. The information contained in this Presentation is provided as at the date of this Presentation and is subject to change without notice.
Statements made in this Presentation may include forward-looking statements. These statements may be identified by the fact that they use words such as "anticipate", "estimate", "should", "expect", "guidance", "project", "intend", "plan", "believe", and/or other words and terms of similar meaning in connection with, among other things, any discussion of results of operations, financial condition, liquidity, prospects, growth, strategies or developments in the industry in which we operate. Such statements, including specifically any guidance or projection, are based on management's current intentions, expectations or beliefs and involve inherent risks, assumptions and uncertainties, including factors that could delay, divert or change any of them.
Forward-looking statements contained in this Presentation and, in particular, in any relevant guidance, regarding trends or current activities are not guarantees of future performance and are subject to risks, uncertainties, and assumptions that are difficult to predict because they relate to events and depend on circumstances that may may/will occur in the future therefore should not be taken as a representation that such trends or activities will continue in the future. Actual outcomes, results and other future events may differ materially from those expressed or implied by the statements and guidance contained herein. Such differences may adversely affect the outcome and financial effects of the plans and events described herein and may result from, among other things, changes in economic, business, competitive, technological, strategic or regulatory factors and other factors affecting the business and operations of the company. Estimated and assumptions are inherently uncertain and are subject to risks that are outside of the company's control. Any guidance and statement refers to events and depend upon circumstances that may or may not verify in the future and refer only as of the date hereof. Therefore the Company's actual results may differ materially and adversely from those expressed or implied in any forward-looking statements. Neither doValue S.p.A. nor any of its affiliates is under any obligation, and each such entity expressly disclaims any such obligation, to update, revise or amend any forward-looking statements, whether as a result of new information, future events or otherwise.
You should not place undue reliance on any such forward-looking statements and or guidance, which speak only as of the date of this Presentation. The inclusion of the projections herein should not be regarded as an indication that the doValue considers the latter to be a reliable prediction of future events and the projections should not be relied upon as such. Use of different methods for preparing, calculating or presenting information may lead to different results and such differences may be material. It should be noted that past performance is not a guide to future performance. Please also note that interim results are not necessarily indicative of full-year results.
By reviewing the Presentation, you acknowledge that you are knowledgeable and experienced with respect to its financial and business aspects and that you will conduct your own independent investigations with respect to the accuracy, completeness and suitability of the matters referred to in the Presentation should you choose to use or rely on it, at your own risk, for any purpose.
No representation, warranty or undertaking, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the Information or the opinions contained therein.
The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to the Information, including any financial data or forward-looking statements, and will not publicly release any revisions it may make to the Information that may result from any change in the Company's expectations, any change in events, conditions or circumstances on which these forward-looking statements are based, or other events or circumstances arising after the date of this document. Market data used in the Information not attributed to a specific source are estimates of the Company and have not been independently verified.
Davide Soffietti, in his position as manager responsible for the preparation of financial reports, certifies pursuant to paragraph 2, article 154-bis of the Legislative Decree n. 58/1998, that data and accounting information disclosures herewith set forth correspond to the company's evidence and accounting books and entries.


Daniele Della Seta Head of Group M&A, Strategic Finance and Investor Relations [email protected]


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.